Guideline
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Affiliations
- PMID: 8652811
Item in Clipboard
Guideline
National Cancer Institute-sponsored Working Group guidelines for chronic lymphocytic leukemia: revised guidelines for diagnosis and treatment
Blood.
.
Free article
No abstract available
Comment in
-
Lymphocytes, B lymphocytes, and clonal CLL cells: observations on the impact of the new diagnostic criteria in the 2008 Guidelines for Chronic Lymphocytic Leukemia (CLL).Blood. 2009 Jun 18;113(25):6496-7; author reply 6497-8. doi: 10.1182/blood-2008-07-166710. Blood. 2009. PMID: 19541838 No abstract available.
-
Clearly defined response criteria evaluating treatment of CLL patients in clinical research trials.Blood. 2010 Sep 9;116(10):1817; author reply 1817-8. doi: 10.1182/blood-2010-03-274035. Blood. 2010. PMID: 20829381 No abstract available.
Similar articles
-
Revision of the guidelines for diagnosis and therapy of chronic lymphocytic leukemia (CLL).Best Pract Res Clin Haematol. 2007 Sep;20(3):469-77. doi: 10.1016/j.beha.2007.02.002. Best Pract Res Clin Haematol. 2007. PMID: 17707834
-
Guidelines for clinical protocols for chronic lymphocytic leukemia: recommendations of the National Cancer Institute-sponsored working group.Am J Hematol. 1988 Nov;29(3):152-63. doi: 10.1002/ajh.2830290307. Am J Hematol. 1988. PMID: 3189311
-
Chronic lymphoproliferative disorders.Rev Invest Clin. 1994 Apr;Suppl:52-8. Rev Invest Clin. 1994. PMID: 7886310 Review. No abstract available.
-
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines.Blood. 2008 Jun 15;111(12):5446-56. doi: 10.1182/blood-2007-06-093906. Epub 2008 Jan 23. Blood. 2008. PMID: 18216293 Free PMC article.
-
Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.J Natl Compr Canc Netw. 2020 Feb;18(2):185-217. doi: 10.6004/jnccn.2020.0006. J Natl Compr Canc Netw. 2020. PMID: 32023533
Cited by
-
Clinical safety and pharmacological profile of the HLA-DR antibody 1D09C3 in patients with B cell chronic lymphocytic leukemia and lymphoma: results from a phase I study.Cancer Immunol Immunother. 2012 Dec;61(12):2367-73. doi: 10.1007/s00262-012-1362-x. Epub 2012 Oct 23. Cancer Immunol Immunother. 2012. PMID: 23090290 Free PMC article. Clinical Trial.
-
Phase I study of the anti-CD40 humanized monoclonal antibody lucatumumab (HCD122) in relapsed chronic lymphocytic leukemia.Leuk Lymphoma. 2012 Nov;53(11):2136-42. doi: 10.3109/10428194.2012.681655. Epub 2012 Jun 12. Leuk Lymphoma. 2012. PMID: 22475052 Free PMC article. Clinical Trial.
-
Impact of age on outcomes after initial therapy with chemotherapy and different chemoimmunotherapy regimens in patients with chronic lymphocytic leukemia: results of sequential cancer and leukemia group B studies.J Clin Oncol. 2013 Feb 1;31(4):440-7. doi: 10.1200/JCO.2011.41.5646. Epub 2012 Dec 10. J Clin Oncol. 2013. PMID: 23233702 Free PMC article.
-
Costimulated tumor-infiltrating lymphocytes are a feasible and safe alternative donor cell therapy for relapse after allogeneic stem cell transplantation.Blood. 2012 Mar 22;119(12):2956-9. doi: 10.1182/blood-2011-09-378398. Epub 2012 Jan 30. Blood. 2012. PMID: 22289893 Free PMC article. Clinical Trial.
-
Richter transformation with c-MYC overexpression: report of three cases.Int J Clin Exp Pathol. 2015 Jun 1;8(6):7540-6. eCollection 2015. Int J Clin Exp Pathol. 2015. PMID: 26261666 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
